EN
IT
DE
JP
CN
ES
Choose a language
EN
IT
DE
JP
CN
ES
Stevanato Group through its historical brand Ompi provides a wide range of washed, siliconized and pre-sterilized EZ-fill® syringes systems. Available in a range of sizes from 0,5 ml to 5 mL with staked needle, Luer cone or Luer lock adapter. Bulk syringe systems are available with or without staked needle and provided in trays.
Alba® EZ-fill® syringes represent the best-in-class solution for biologics and ophthalmic applications addressing the key requirements of protein-based drugs, and minimizing adsorption, aggregation and inorganic extractable interaction.
All Alba® EZ-fill® products have an internal coating, based on standard silicone oil, which is cross-linked to form a chemical bond with the glass surface. It ensures that particle levels - caused by silicone migration during container storage - are significantly lower than ones using standard siliconization technologies. Moreover, the internal treatment offers superior gliding performance, reducing the risk of functional issues when combined with auto-injectors.
Due to the excellent properties of the layer, Alba® platform mitigates packaging-related risks and enhances drug-interaction stability.
STACKED NEEDLE
LUER
0.5 ml
1.0 ml long
2.25 ml
Particle reduction
Minimized subvisible particles versus conventional sprayed-on siliconized containers to alleviate potential drug-silicone interaction.
Optimized break-loose and glide performance
Silicone lubricant layer integrity, optimized to withstand challenging formulations and aggressive conditions, helps conserve gliding performances throughout the drug shelf-life.
Reduction risk of stalling and injection time variation
The low silicone-drug interaction helps to maintain the injection time and dose delivery with an auto-injector.
Inorganic extractable mitigation
A barrier between the drug and the glass reduces the amount of inorganic extractables.
Time stability
Alba® inner coating does not undergo critical variations after contact with the placebo solution over a period of 6 months (tested @40°C/75%RH).
Particle reduction
Minimized subvisible particles versus conventional sprayed-on siliconized containers to alleviate potential drug-silicone interaction.
Optimized break-loose and glide performance
Silicone lubricant layer integrity, optimized to withstand challenging formulations and aggressive conditions, helps conserve gliding performances throughout the drug shelf-life.
Reduction risk of stalling and injection time variation
The low silicone-drug interaction helps to maintain the injection time and dose delivery with an auto-injector.
Inorganic extractable mitigation
A barrier between the drug and the glass reduces the amount of inorganic extractables.
Time stability
Alba® inner coating does not undergo critical variations after contact with the placebo solution over a period of 6 months (tested @40°C/75%RH).
Protein-based therapeutics
Ophthalmic applications
Protein-based therapeutics
Ophthalmic applications
Extremely safe, compatible, and extremely resistant, Nexa ® syringe is the preferred solution for high-value sensitive injectables drug products.
Nexa® glass performance level is now available also on Nexa FlexTM: Our State-of-the-Art Polymer Syringes. Learn nore.
Nexa® syringes have been specifically designed to meet the dimensional requirements of auto-injectors and to ensure excellent mechanical resistance when compared to a standard syringe. These durable properties are derived through optimized product handling throughout the entire manufacturing process (no glass-to-glass contact and limited glass-to-metal contact). Advanced in-line inspection technologies carefully check products before release, minimizing the risk of in-line breakages during filling operations and reducing the number of filled rejects.
Drug stability is ensured by an ultra-low tungsten level and an optimized silicone-oil distribution along the barrel provides enhanced gliding performance, a key aspect when integrating a syringe into a drug delivery device.
STACKED NEEDLE
LUER
1.0 ml long
2.25 ml
Ultra-low tungsten
Optimized break-loose and glide performance
Easily integrates with drug delivery systems
Ultra-low tungsten
Optimized break-loose and glide performance
Easily integrates with drug delivery systems
Biologics
Biologics
Fina® provides a flexible platform for designing a customized prefilled syringe solution. The line boasts a wide range of container sizes and matching components.
Fina® syringes are manufactured on fully automated production lines featuring 100% inline camera controls, inspecting all critical phases. As a result of using validated manufacturing processes, Fina® syringes have excellent mechanical performance and cosmetic appearance - fulfilling the most stringent AQL standards.
STACKED NEEDLE
LUER
0.5 ml
1.0 ml long
1.0 ml Short
1.25 ml
1.5 ml
2.25 ml
3.0 ml
5.0 ml
5.0 ml bypass
Compliant with PH.Eur., USP and JP for applicable parts
Our Regulatory Affairs team can support customer drug applications and provide authorization of DMF submissions to US FDA and Health Canada
Compliant with PH.Eur., USP and JP for applicable parts
Our Regulatory Affairs team can support customer drug applications and provide authorization of DMF submissions to US FDA and Health Canada
Heparin
Vaccines
Water For Injection
Heparin
Vaccines
Water For Injection
As a system supplier, Stevanato Group works hand in hand with rubber manufacturers to supply best-in-class components for each intended use. The plunger rod and backstop (extended finger flange) are designed for maximum compatibility with industry rubber components and safety devices.
A full range of colors and materials are available for product differentiation, dose differentiation or improved machinability.
Plunger Rods
Backstops
(Extended Finger Flange)
Plungers
Plunger Rods
Backstops
(Extended Finger Flange)
Plungers
Our Special Thin-Wall needle is a 27G and 29G ½” 5B needle with an enlarged internal channel diameter to optimize the delivery of highly viscous drug formulations without the need for bigger needles, thereby satisfying auto-injector device requirements and enhancing the overall patient experience.
